Product — Remaining performance obligations, amount
GE HealthCare Technologies Product — Remaining performance obligations, amount increased by 2.8% to $5.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $4.60B to $5.14B. Over 2 years (FY 2023 to FY 2025), Product — Remaining performance obligations, amount shows relatively stable performance with a -1.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increasing backlog signals strong future revenue visibility and high demand, whereas a declining backlog may indicate slowing future growth.
Detailed definition
Represents the total transaction price allocated to performance obligations that are unsatisfied or partially unsatisfie...
Peer comparison
Standard metric for companies with long-cycle capital equipment sales.
gehc_segment_product_remaining_performance_obligations_amountHistorical Data
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.97B | $4.99B | $4.87B | $4.93B | $4.74B | $4.65B | $4.81B | $4.76B | $4.60B | $4.81B | $4.90B | $5.00B | $5.14B |
| QoQ Change | — | +0.5% | -2.5% | +1.3% | -3.8% | -2.0% | +3.4% | -1.1% | -3.3% | +4.5% | +2.0% | +2.1% | +2.8% |
| YoY Change | — | — | — | — | -4.5% | -6.9% | -1.2% | -3.5% | -3.0% | +3.4% | +1.9% | +5.2% | +11.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's product — remaining performance obligations, amount?
- GE HealthCare Technologies (GEHC) reported product — remaining performance obligations, amount of $5.14B in Q1 2026.
- How has GE HealthCare Technologies's product — remaining performance obligations, amount changed year-over-year?
- GE HealthCare Technologies's product — remaining performance obligations, amount increased by 11.8% year-over-year, from $4.60B to $5.14B.
- What is the long-term trend for GE HealthCare Technologies's product — remaining performance obligations, amount?
- Over 2 years (2023 to 2025), GE HealthCare Technologies's product — remaining performance obligations, amount has grown at a -1.1% compound annual growth rate (CAGR), from $19.75B to $19.30B.
- What does product — remaining performance obligations, amount mean?
- The total value of product orders received but not yet delivered or recognized as revenue.